Aman U Buzdar Selected Research

Mastectomy (Mammectomy)

7/2006	Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer.
5/2006	Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer: the Pre-Operative "Arimidex" Compared to Tamoxifen (PROACT) trial.
6/2005	Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
12/2004	Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.
6/2004	The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
5/2004	T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
7/2002	Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.
1/2002	Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aman U Buzdar Research Topics

Disease

146	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2002
56	Neoplasms (Cancer) 01/2022 - 01/2002
18	Pathologic Complete Response 01/2022 - 06/2005
7	Neoplasm Metastasis (Metastasis) 06/2010 - 08/2002
6	Residual Neoplasm 04/2017 - 04/2004
5	Endometrial Neoplasms (Endometrial Cancer) 02/2008 - 12/2002
4	Disease Progression 01/2018 - 05/2004
4	Uterine Hemorrhage (Uterine Bleeding) 02/2008 - 12/2002
3	Lymphatic Metastasis 05/2012 - 03/2006
3	Cardiotoxicity 09/2007 - 11/2002
3	Carcinoma (Carcinomatosis) 02/2006 - 04/2004
2	Triple Negative Breast Neoplasms 01/2022 - 05/2013
2	Exanthema (Rash) 04/2015 - 01/2013
2	Febrile Neutropenia 01/2011 - 02/2010
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2011 - 01/2007
2	Cognitive Dysfunction 07/2010 - 08/2004
2	Obesity 09/2008 - 09/2008
2	Lobular Carcinoma 11/2006 - 01/2005
2	Inflammatory Breast Neoplasms 03/2006 - 02/2004
2	Male Breast Neoplasms (Male Breast Cancer) 12/2005 - 06/2002
2	Heart Failure 06/2005 - 11/2002
1	Overweight 01/2016
1	Pain (Aches) 04/2015
1	Digestive System Diseases 01/2013
1	Anemia 07/2011
1	Infections 01/2011
1	Thrombocytopenia (Thrombopenia) 01/2011
1	Myalgia 02/2010
1	Arthralgia (Joint Pain) 09/2008
1	Arthritis (Polyarthritis) 09/2008
1	Osteoporosis 07/2008

Drug/Important Bio-Agent (IBA)

33	Tamoxifen FDA LinkGeneric 05/2013 - 01/2002
31	Estrogen ReceptorsIBA 01/2019 - 01/2002
28	Anastrozole (Arimidex)FDA LinkGeneric 01/2021 - 06/2002
28	Hormones (Hormone)IBA 04/2015 - 10/2002
27	Aromatase InhibitorsIBA 01/2020 - 11/2002
22	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2002
21	Paclitaxel (Taxol)FDA LinkGeneric 12/2013 - 04/2002
20	Fluorouracil (Carac)FDA LinkGeneric 12/2013 - 01/2002
19	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2002
16	Trastuzumab (Herceptin)FDA Link 03/2016 - 06/2005
12	Letrozole (Femara)FDA LinkGeneric 05/2007 - 11/2002
11	Progesterone Receptors (Progesterone Receptor)IBA 05/2013 - 10/2002
11	AnthracyclinesIBA 05/2012 - 05/2002
9	exemestane (Aromasin)FDA Link 01/2020 - 01/2003
8	Estrogens (Estrogen)FDA Link 01/2021 - 12/2002
8	human ERBB2 proteinIBA 04/2017 - 06/2005
7	Epirubicin (Ellence)FDA LinkGeneric 12/2013 - 06/2005
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2008
6	Fulvestrant (Faslodex)FDA Link 01/2020 - 01/2003
5	taxaneIBA 07/2011 - 10/2004
5	Megestrol Acetate (Borea)FDA LinkGeneric 01/2004 - 11/2002
4	ErbB Receptors (EGF Receptor)IBA 04/2015 - 10/2002
4	Taxoids (Taxanes)IBA 12/2009 - 01/2003
3	Aromatase (CYP19)IBA 07/2017 - 12/2002
3	Lapatinib (GW572016)FDA Link 03/2016 - 01/2013
3	Selective Estrogen Receptor Modulators (SERM)IBA 09/2013 - 07/2008
3	Estrogen Receptor AntagonistsIBA 09/2008 - 01/2003
3	Estrogen Receptor Modulators (Antiestrogen)IBA 02/2006 - 01/2003
2	DNA (Deoxyribonucleic Acid)IBA 04/2013 - 03/2011
2	Docetaxel (Taxotere)FDA Link 05/2012 - 03/2012
2	Capecitabine (Xeloda)FDA Link 03/2012 - 03/2008
2	Messenger RNA (mRNA)IBA 11/2011 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 10/2010 - 09/2004
2	Tumor Biomarkers (Tumor Markers)IBA 10/2010 - 01/2008
2	LY 353381 (LY353381)IBA 07/2008 - 11/2007
2	Epothilones (Epothilone)IBA 03/2008 - 12/2007
2	thiamine triphosphorate (TTP)IBA 09/2004 - 05/2004
1	tipifarnib (R115777)IBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Estrone FDA Link 07/2017
1	Androstenedione (4 Androstene 3,17 dione)IBA 07/2017
1	TOR Serine-Threonine KinasesIBA 05/2013
1	Epidermal Growth Factor (EGF)IBA 05/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2013
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2013
1	N 30IBA 05/2012
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2012
1	MicroRNAs (MicroRNA)IBA 05/2012
1	Carboplatin (JM8)FDA LinkGeneric 05/2012
1	HematinicsIBA 07/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2011
1	Blood Proteins (Serum Proteins)IBA 10/2010
1	Albumin-Bound Paclitaxel FDA Link 02/2010
1	Growth Factor ReceptorsIBA 09/2008
1	LipidsIBA 07/2008
1	desoxyepothilone B (epothilone D)IBA 03/2008
1	ixabepilone (BMS 247550)FDA Link 03/2008

Therapy/Procedure

56	Therapeutics 01/2019 - 01/2002
52	Drug Therapy (Chemotherapy) 01/2019 - 01/2002
34	Neoadjuvant Therapy 01/2022 - 01/2002
10	Adjuvant Chemotherapy 01/2013 - 01/2002
9	Radiotherapy 01/2007 - 07/2002
8	Mastectomy (Mammectomy) 07/2006 - 01/2002
4	Segmental Mastectomy (Lumpectomy) 03/2011 - 04/2002
2	Aftercare (After-Treatment) 10/2004 - 02/2004
1	Withholding Treatment 07/2010
1	Lymph Node Excision (Lymph Node Dissection) 06/2010
1	Combined Modality Therapy 12/2008